earnings
confidence high
sentiment negative
materiality 0.75
Bio-Rad Q1 revenue falls 4% to $585M; full-year 2025 outlook moderated on uncertainty
BIO-RAD LABORATORIES, INC.
2025-Q1 EPS reported
$2.29
revenue$585,400,000
- Revenue $585.4M, down from $610.8M YoY; GAAP gross margin 52.3% vs 53.4%.
- GAAP net income $64.0M ($2.29 EPS) vs $383.9M ($13.45 EPS) in Q1 2024.
- Non-GAAP net income $71.0M ($2.54 EPS) vs $65.3M ($2.30 EPS) YoY.
- CEO cites market uncertainty; moderating full-year 2025 outlook.
- Non-GAAP gross margin 53.8%, slightly down from 54.2% a year ago.